• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌相关炎症细胞因子:正在研究的生物标志物。

Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers.

机构信息

TCM&VIP Inpatient Department, Sun Yat-sen University Cancer Center, Guangzhou, China.

State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Front Immunol. 2024 Oct 17;15:1448012. doi: 10.3389/fimmu.2024.1448012. eCollection 2024.

DOI:10.3389/fimmu.2024.1448012
PMID:39483474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11524805/
Abstract

Nasopharyngeal carcinoma (NPC) is a neoplasm related to inflammation; the expression of cytokines, such as CCL3, CCL4, CCL20, IL-1α, IL-1β, IL-6, IL-8, and IL-10, among others, is presumed to be associated with NPC occurrence and development. Therefore, the circulating levels of these cytokines may be potential biomarkers for assessing tumor aggressiveness, exploring cellular interactions, and monitoring tumor therapeutic responses. Numerous scholars have comprehensively explored the putative mechanisms through which these inflammatory factors affect NPC progression and therapeutic responses. Moreover, investigations have focused on elucidating the correlation between the systemic levels of these cytokines and the incidence and prognosis of NPC. This comprehensive review aims to delineate the advancements in research concerning the relationship between inflammatory factors and NPC while considering their prospective roles as novel prognostic and predictive biomarkers in the context of NPC.

摘要

鼻咽癌(NPC)是一种与炎症相关的肿瘤;细胞因子的表达,如 CCL3、CCL4、CCL20、IL-1α、IL-1β、IL-6、IL-8 和 IL-10 等,被认为与 NPC 的发生和发展有关。因此,这些细胞因子的循环水平可能是评估肿瘤侵袭性、探索细胞相互作用和监测肿瘤治疗反应的潜在生物标志物。许多学者已经全面探讨了这些炎症因子影响 NPC 进展和治疗反应的可能机制。此外,研究还集中在阐明这些细胞因子的系统水平与 NPC 的发病率和预后之间的相关性。本综述旨在阐述炎症因子与 NPC 之间关系的研究进展,同时考虑它们作为 NPC 中新型预后和预测生物标志物的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a687/11524805/da588a2b2557/fimmu-15-1448012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a687/11524805/da588a2b2557/fimmu-15-1448012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a687/11524805/da588a2b2557/fimmu-15-1448012-g001.jpg

相似文献

1
Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers.鼻咽癌相关炎症细胞因子:正在研究的生物标志物。
Front Immunol. 2024 Oct 17;15:1448012. doi: 10.3389/fimmu.2024.1448012. eCollection 2024.
2
Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma.巨噬细胞炎性蛋白(MIP)-1α 和 MIP-1β 的减少增加了患鼻咽癌的风险。
Cancer Commun (Lond). 2018 Apr 3;38(1):7. doi: 10.1186/s40880-018-0279-y.
3
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.血浆巨噬细胞移动抑制因子和 CCL3 可作为鉴别 EBV 壳抗原特异性 IgA 阳性的鼻咽癌高危人群的潜在生物标志物
Cancer Res Treat. 2019 Jan;51(1):378-390. doi: 10.4143/crt.2018.070. Epub 2018 May 29.
4
Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.基于随机生存森林建立的甘油三酯-炎症评分预测鼻咽癌患者生存:一项回顾性研究。
Front Immunol. 2024 Apr 26;15:1375931. doi: 10.3389/fimmu.2024.1375931. eCollection 2024.
5
Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).根治性调强放疗(IMRT)治疗后鼻咽癌患者血浆细胞因子和趋化因子表达水平的变化
PLoS One. 2017 Feb 16;12(2):e0172264. doi: 10.1371/journal.pone.0172264. eCollection 2017.
6
Extensive serum biomarker analysis in patients with nasopharyngeal carcinoma.鼻咽癌患者的广泛血清生物标志物分析。
Cytokine. 2019 Jun;118:107-114. doi: 10.1016/j.cyto.2018.04.031. Epub 2018 May 11.
7
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.外泌体亲环素 A 作为一种新型的非侵入性生物标志物用于 EBV 相关鼻咽癌。
Cancer Med. 2019 Jun;8(6):3142-3151. doi: 10.1002/cam4.2185. Epub 2019 May 7.
8
Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.基于免疫炎症的指数的开发和验证,用于预测鼻咽癌患者的临床结局。
J Cell Mol Med. 2020 Aug;24(15):8326-8349. doi: 10.1111/jcmm.15097. Epub 2020 Jun 30.
9
Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.鉴定血浆中的 7 个 microRNA 特征作为鼻咽癌检测有前途的生物标志物。
Cancer Med. 2020 Feb;9(3):1230-1241. doi: 10.1002/cam4.2676. Epub 2019 Dec 19.
10
Increased Risk of Nasopharyngeal Carcinoma with Increasing Levels of Diet-Associated Inflammation in an Italian Case-Control Study.意大利一项病例对照研究表明,饮食相关炎症水平升高会增加患鼻咽癌的风险。
Nutr Cancer. 2016 Oct;68(7):1123-30. doi: 10.1080/01635581.2016.1216137. Epub 2016 Aug 26.

引用本文的文献

1
Association of Single-Nucleotide Polymorphisms on and Genes with the Risk and Prognosis of Undifferentiated Nasopharyngeal Cancer.和基因上的单核苷酸多态性与未分化鼻咽癌的风险及预后的关联
Int J Mol Sci. 2025 Sep 1;26(17):8486. doi: 10.3390/ijms26178486.

本文引用的文献

1
Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study.血清炎症标志物作为伴肝转移鼻咽癌的预后标志物:一项多中心回顾性研究。
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4315-4324. doi: 10.1007/s00405-024-08649-2. Epub 2024 Apr 20.
2
The effect of interleukin-33 expression on prognosis in patients with nasopharyngeal carcinoma.白细胞介素-33表达对鼻咽癌患者预后的影响。
Acta Otorrinolaringol Esp (Engl Ed). 2025 Mar-Apr;76(2):76-82. doi: 10.1016/j.otoeng.2024.01.011. Epub 2024 Feb 24.
3
Advances of biomarkers in nasopharyngeal carcinoma's early detection.
生物标志物在鼻咽癌早期检测中的进展
Sci Bull (Beijing). 2024 Jan 30;69(2):141-145. doi: 10.1016/j.scib.2023.11.059. Epub 2023 Dec 1.
4
Interleukin-10 in cancer immunotherapy: from bench to bedside.白细胞介素-10 在癌症免疫治疗中的作用:从基础到临床。
Trends Cancer. 2023 Sep;9(9):716-725. doi: 10.1016/j.trecan.2023.05.003. Epub 2023 Jun 14.
5
Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapy.信号转导与转录激活因子3(STAT3)在鼻咽癌发病机制中的作用及其在抗癌治疗中的意义。
Front Oncol. 2022 Oct 13;12:1021179. doi: 10.3389/fonc.2022.1021179. eCollection 2022.
6
Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy.血清炎症因子检测对接受根治性放疗联合辅助化疗的非转移性鼻咽癌患者的预后价值
Cancer Manag Res. 2022 Sep 16;14:2763-2772. doi: 10.2147/CMAR.S371922. eCollection 2022.
7
Inflammation: the incubator of the tumor microenvironment.炎症:肿瘤微环境的温床。
Trends Cancer. 2022 Nov;8(11):901-914. doi: 10.1016/j.trecan.2022.07.002. Epub 2022 Jul 28.
8
Plasma secretome analyses identify IL-8 and nitrites as predictors of poor prognosis in nasopharyngeal carcinoma patients.血浆分泌组分析鉴定出白细胞介素-8 和亚硝酸盐作为鼻咽癌患者预后不良的预测因子。
Cytokine. 2022 May;153:155852. doi: 10.1016/j.cyto.2022.155852. Epub 2022 Mar 9.
9
Necrosis Factor-α (TNF-α) and the Presence of Macrophage M2 and T Regulatory Cells in Nasopharyngeal Carcinoma.坏死因子-α(TNF-α)与鼻咽癌中巨噬细胞 M2 和 T 调节细胞的存在。
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2363-2370. doi: 10.31557/APJCP.2021.22.8.2363.
10
Nasopharyngeal carcinoma: an evolving paradigm.鼻咽癌:一个不断发展的范例。
Nat Rev Clin Oncol. 2021 Nov;18(11):679-695. doi: 10.1038/s41571-021-00524-x. Epub 2021 Jun 30.